Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C Strain

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Experimental and Clinical Psychopharmacology|October 4, 2016
Initial feasibility and validity of a prospective memory training program in a substance use treatment populationMary M Sweeney, Olga Rass, Patrick S Johnson, et al.
Sleep|January 30, 2024
Suvorexant alters dynamics of the sleep-electroencephalography-power spectrum and depressive-symptom trajectories during inpatient opioid withdrawalMatthew J Reid, Kelly E Dunn, Liza Abraham, et al.
International Review of Psychiatry (Abingdon, England)|January 3, 2015
Behavioural health interventions in the Johns Hopkins Community Health Partnership: integrated care as a component of health systems transformationAnita S Everett, Jennifer Reese, Janelle Coughlin, et al.
Scientific Reports|November 19, 2020
Experimental sleep disruption attenuates morphine analgesia: findings from a randomized trial and implications for the opioid abuse epidemicMichael T Smith, Chung Jung Mun, Bethany Remeniuk, et al.
Journal of Psychopharmacology (Oxford, England)|March 20, 2026
Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelicsJack E Henningfield, Frederick S Barrett, Suzette M Evans, et al.
The Journal of Pain|February 10, 2015
Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic ReviewShannon M Smith, Florence Paillard, Andrew McKeown, et al.
Drug and Alcohol Dependence|November 5, 2019
Craving and opioid use disorder: A scoping reviewBethea A Kleykamp, Marta De Santis, Robert H Dworkin, et al.
Neuroscience and Biobehavioral Reviews|October 6, 2023
Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent resultsSophia Linguiti, Jacob W Vogel, Valerie J Sydnor, et al.
Journal of Addiction Medicine|June 4, 2013
A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependenceRaye Z Litten, Megan L Ryan, Joanne B Fertig, et al.
Alcoholism, Clinical and Experimental Research|February 14, 2012
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patientsJoanne B Fertig, Megan L Ryan, Daniel E Falk, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Experimental and Clinical Psychopharmacology|October 4, 2016
Initial feasibility and validity of a prospective memory training program in a substance use treatment populationMary M Sweeney, Olga Rass, Patrick S Johnson, et al.
Sleep|January 30, 2024
Suvorexant alters dynamics of the sleep-electroencephalography-power spectrum and depressive-symptom trajectories during inpatient opioid withdrawalMatthew J Reid, Kelly E Dunn, Liza Abraham, et al.
International Review of Psychiatry (Abingdon, England)|January 3, 2015
Behavioural health interventions in the Johns Hopkins Community Health Partnership: integrated care as a component of health systems transformationAnita S Everett, Jennifer Reese, Janelle Coughlin, et al.
Scientific Reports|November 19, 2020
Experimental sleep disruption attenuates morphine analgesia: findings from a randomized trial and implications for the opioid abuse epidemicMichael T Smith, Chung Jung Mun, Bethany Remeniuk, et al.
Journal of Psychopharmacology (Oxford, England)|March 20, 2026
Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelicsJack E Henningfield, Frederick S Barrett, Suzette M Evans, et al.
The Journal of Pain|February 10, 2015
Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic ReviewShannon M Smith, Florence Paillard, Andrew McKeown, et al.
Drug and Alcohol Dependence|November 5, 2019
Craving and opioid use disorder: A scoping reviewBethea A Kleykamp, Marta De Santis, Robert H Dworkin, et al.
Neuroscience and Biobehavioral Reviews|October 6, 2023
Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent resultsSophia Linguiti, Jacob W Vogel, Valerie J Sydnor, et al.
Journal of Addiction Medicine|June 4, 2013
A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependenceRaye Z Litten, Megan L Ryan, Joanne B Fertig, et al.
Alcoholism, Clinical and Experimental Research|February 14, 2012
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patientsJoanne B Fertig, Megan L Ryan, Daniel E Falk, et al.
Pageof 16